Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. - Wikidata - awgldk - TriplyDB

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

http://www.wikidata.org/entity/Q44211857

about

A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial Mechanisms of sex disparities in influenza pathogenesis Protection of young children from influenza through universal vaccination.Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.Sex-based biology and the rational design of influenza vaccination strategies.Influenza A (H5N1) pandemic prototype vaccine Fluval.Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.The impact of sex, gender and pregnancy on 2009 H1N1 disease Sex- and age-related differences in morbidity rates of 2009 pandemic influenza A H1N1 virus of swine origin in Japan Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study.Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.New technologies for influenza vaccines.Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation Humoral responses to independent vaccinations are correlated in healthy boosted adults Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.How sex and age affect immune responses, susceptibility to infections, and response to vaccination Sex-based differences in immune function and responses to vaccination.Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination.Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.Sex and Gender Impact Immune Responses to Vaccines Among the Elderly Adversomics: a new paradigm for vaccine safety and design.Acute exercise enhancement of pneumococcal vaccination response: a randomised controlled trial of weaker and stronger immune response Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.Risk of anaphylaxis after vaccination in children and adults Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.Tularemia vaccine development: paralysis or progress?Age-specific genetic and antigenic variations of influenza A viruses in Hong Kong, 2013-2014.Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy.

P2860

Q24623902-0BD381D9-7E7D-4B9D-90D4-6DC7AE75101D Q26865438-20E69506-0C03-4EDB-AFF5-B03F5A32983B Q27693242-A4DD6001-1ADD-4EE6-8CDB-631D8CAE470B Q28655545-0B49D50A-65F4-4DE8-8CA8-116FB8752A1A Q30356492-3907EB1F-D8C7-4CA5-9A80-D0F7EACB17B1 Q30363998-37B59B3C-47B6-4997-BB28-B409356DE277 Q30376553-ED1D6BB9-2A7E-4420-9D10-170EE4079502 Q30388996-48980B3D-4640-45A2-AEEF-740EF8E69645 Q30389669-1E2A5CAE-7B5D-41F6-A035-D22B057CCCF0 Q30398193-7E5B2E7E-FF28-405A-8DE8-85FE42743DC5 Q30402509-915BD540-D574-4B11-8555-466199723027 Q30405315-6588740A-0069-4F63-8A26-06260BAEA93E Q30411189-EBF0C155-39AD-4B26-9AF4-D1EC071BCE82 Q30411859-0C4A6B4F-C4F6-4E94-9588-F59A8C5B6B34 Q30419062-50A46B8C-74A7-4D26-8053-0FFA44E40613 Q33541763-F3C72A15-0706-4688-8348-D1634929A7ED Q33899438-C9CD6B44-C44A-4DE6-A926-C6651A7539D1 Q33997400-84AE0107-8346-4186-9CC3-D85C2904929A Q34333819-4D9CAC3B-F906-4B78-93B5-FFC39FEE826E Q35068548-9416ECFF-4A45-4713-9C5C-3160CE926718 Q35148060-1C6EB7E5-D547-440B-AD89-F58E75B81018 Q35167137-A924D58E-C5D5-4A57-B703-DCA2DD80A25F Q35191251-6D984BDF-413F-4E2E-A1C5-BAE0DACE57CC Q35225020-06D501C6-0A59-4B13-B1EA-69A8E66E32C3 Q35503099-63E2CA74-CA68-40C5-86D7-7BDF0ABA9419 Q35527150-07389519-C98C-4790-A0D1-E490F4480E37 Q35661949-04E2FE2F-C6EE-40E3-A33C-3CA91CFE26A1 Q35682690-3CECDAA7-6BFD-4ABD-BDF8-F7B2A354CA2F Q35744127-5C493294-2FE7-4BF0-8522-2204CF5B6B4D Q35887557-56BD86DC-C138-4C75-A2BD-FF13B036DFF7 Q36009663-E5A181A5-3995-4FF2-8DE7-3377154B2C07 Q36240727-FDD5818F-ECFB-4D81-9072-A630F2007BA1 Q36242667-32857B03-E890-470A-B676-6B015DA767D2 Q36275718-FF74A59D-2F45-44CB-965B-085CBD6BC6C6 Q36493907-6A59E16E-F4E7-4522-9B49-BBAD6CD1F8EA Q36665226-C646D5F2-8674-4E56-BA80-4AC6CA65754A Q36705828-BF6CE211-9AD7-4B49-9A9B-9E32506F4004 Q36908692-A13F0647-2881-464A-9D23-8D23A335EB6F Q37121810-1302F0DB-B5B8-4ECF-9F4B-1D6C835C7430 Q37681539-4060D78C-90F1-4ADB-90EA-FD9AEADBC3C9

P2860

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

http://www.wikidata.org/entity/Q44211857

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Half- vs full-dose trivalent i ...... x effects on immune responses.

@en

Half- vs full-dose trivalent i ...... x effects on immune responses.

@nl

type

label

Half- vs full-dose trivalent i ...... x effects on immune responses.

@en

Half- vs full-dose trivalent i ...... x effects on immune responses.

@nl

prefLabel

Half- vs full-dose trivalent i ...... x effects on immune responses.

@en

Half- vs full-dose trivalent i ...... x effects on immune responses.

@nl

P1433

Q44211857-05012C10-D2BE-4E63-9B3F-FDCCB29BBBFB

P1476

Q44211857-8343DC7A-B30C-4FE6-97EB-9D5F6D47F90D

P2093

Q44211857-0FF03E14-1150-4CA8-B6EE-BF3461F077CA

Q44211857-10FB54E8-8196-4451-9FFE-662AC4C6AB2B

Q44211857-378B2F68-D73C-4769-A145-7428C858AB2D

Q44211857-4EEA1A2D-7B89-480B-AFD2-940592CDDE73

Q44211857-54AFB640-D5FE-473D-9791-C05B056D6AF9

Q44211857-6975DAA6-F73C-4019-B099-433B8E77E095

Q44211857-6C047411-3B9B-4CCF-8CA5-71AC3CDDE0EF

Q44211857-A2BC8A75-364D-4CB5-8827-8F78EBCB54FE

Q44211857-C41C98D9-6704-4A0A-B657-8543B6AA772A

Q44211857-ECABA151-1940-414E-931B-1F84BB84D92F

P304

Q44211857-1FF74376-440A-41A4-9A3E-F398F3661BBF

P31

Q44211857-A2345478-9E86-4F5C-A8F5-F84CB4502A6B

P356

Q44211857-8DDE0953-73C9-4FD7-A4BC-53B12C7B6654

P407

Q44211857-3149E4EB-FB91-481F-806F-84D4718FDEB2

P433

Q44211857-C822FFD8-25CF-4D39-AFED-CF2BB5D119AA

P478

Q44211857-17345699-749C-43F2-803D-EE553F0DC2C4

P50

Q44211857-03AB6630-1482-4E2C-B506-D42F6EF5ADB0

P577

Q44211857-1B9BF470-AC65-496C-AE37-AA8532272DE1

P698

Q44211857-EF581834-13E6-4CA2-8D92-5FA297F5836A

P356

ARCHINTERNMED.2008.513

P1433

JAMA Internal Medicine

P1476

Half- vs full-dose trivalent i ...... x effects on immune responses.

@en

P2093

Alexander Klimov

http://www.w3.org/2001/XMLSchema#string

Chiung-Yu Huang

http://www.w3.org/2001/XMLSchema#string

John J Treanor

http://www.w3.org/2001/XMLSchema#string

Kristin L Nichol

http://www.w3.org/2001/XMLSchema#string

Mark J VanRaden

http://www.w3.org/2001/XMLSchema#string

Mary M Klote

http://www.w3.org/2001/XMLSchema#string

Michael R Nelson

http://www.w3.org/2001/XMLSchema#string

Nancy J Cox

http://www.w3.org/2001/XMLSchema#string

Renata J M Engler

http://www.w3.org/2001/XMLSchema#string

Walter Reed Health Care System Influenza Vaccine Consortium

http://www.w3.org/2001/XMLSchema#string

P304

2405-2414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2008.513

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19064822

http://www.w3.org/2001/XMLSchema#string